Home›Trial›NCT06908538
NCT06908538RECRUITING

Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain

Study Summary

The goal of this Registry is to see how the device is used when freezing nerves during an amputation procedure.

Conditions
AmputationAmputation of Lower LimbAmputation of Upper LimbAmputation, Limb LossAmputation, Traumatic/SurgeryCryo Analgesia
Interventions / Drugs
cryoablation
View on ClinicalTrials.gov ↗
Sponsor
ATRC
AtriCure Inc
Cardiac Surgery
D36/100
Study Details
Enrollment2000 participants
Primary Completion—
Lead SponsorAtriCure, Inc.
Data Retrieved2026-04-11 02:55:07.545261+00:00
What This Trial Means for Biotech Investors
Trial Phase Context
Status & Expected Data

Currently recruiting: the trial is enrolling patients. A data readout is not expected until after enrollment closes and the follow-up period is complete.

Enrolled: 2,000 participants
Sponsor Catalyst Profile

AtriCure Inc (ATRC) is the sponsoring company for this trial. BiotechSign currently grades this company D (36/100) based on composite catalyst signals across its full pipeline. This trial is one data point in that overall catalyst picture.

ATRC Full Pipeline →All Companies →
Not financial advice. BiotechSign data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.